We, KH Medical is honored to be the unique COVID-19 PCR KIT which has 100% of Sensitivity & 100% of Specificity on FIND Evaluation.
FIND (Foundation for Innovative New Diagnostics) is
WHO Collaborating Centre for Laboratory Strengthening and Diagnostic Technology
Evaluation. FIND is working in partnership with WHO to accelerate development
and access to diagnostics as part of the global response to the COVID-19
This diagnostics resource centre is designed to support policymakers and
healthcare providers with up-to-date information on tests and testing for
SARS-CoV-2 (the causative agent of COVID-19). FIND is conducting independent
evaluations of SARS-CoV-2 molecular tests. Data from these evaluations is current available checking on FIND’s web
All data is made openly accessible on their website
and shared with WHO, in order to help inform procurement and implementation
decisions for countries and health programs – specifically those with limited
capacity to conduct their own independent evaluations.
Verify the analytical
sensitivity, i.e. lower limit of detection, of commercially available COVID-19
NAT diagnostic kits using contrived specimens containing known, limited
quantities of whole virus.
diagnostic performance (sensitivity and specificity) of commercially available
COVID-19 NAT diagnostic kits in previously characterized clinical respiratory
samples (SARS-CoV-2 positive and negative).